The 2018 FLC Awards is now open for nominations. One of the most coveted honors in the technology transfer field, the FLC awards have been presented to over 200 federal laboratories since their inception in 1984. Many of our winning technology transfer efforts have gone on to become products and devices that are indispensable in our daily lives, including:
Inova Genomics Laboratory is thrilled to offer you our exclusive MediMap® PGx (pharmacogenomics) panel – as well as tests for up to two family members, if applicable at your event.
What is MediMap?
MediMap is a one-time genetic test that may indicate how a person will respond to some prescription medications. The test helps guide healthcare providers to better medication choices and doses for their patients. MediMap testing provides information to more effectively manage illnesses and improve patients’ health. To learn more, please visit www.inova.org/MediMap. What’s involved?
All that’s needed is a painless cheek swab, which we will conduct after you have registered by filling out the form below.
The PMatX Yavne incubator will serve Israeli startups and focus on next-generation electronics and advanced materials.
German pharmaceutical, life sciences and chemicals giant Merck Group today announced the founding of a technological innovation laboratory that will function as an incubator for startups in Israel. The incubator, to be called PMatX, will focus on next-generation electronics. The program will be supported by other partners, including printing solutions manufacturer HP and the Battery Ventures fund.
New York City’s existing 1.7 million s/f of life science and research space is currently fully occupied, pushing companies to establish outposts in Westchester County and New Jersey.
According to a report from brokerage firm Transwestern, New York City is facing space constraints as it hosts the highest concentration of academic institutions and the largest life science workforce in the country.
It’s a common trope that government has a lot to learn from Silicon Valley when it comes to technology. But in cybersecurity, Washington is leading the way in many respects.
When federal leaders and lawmakers praise industry’s tech savvy, they’re usually talking about innovation, flexibility and speed to market. IT companies aren’t burdened by a labyrinthine acquisition process. They can shift quickly when customers want something different, abandon failing efforts and push products out at the lowest cost.
DATE AND TIME: Tue, September 19, 20177:30 AM – 10:00 AM EDT
LOCATION: American Visionary Art Museum800 Key Highway JRVC 3rd Floor Baltimore, MD 21230
Already dubbed a ‘tech hub’, the Baltimore-Washington region has built a solid foundation in cyber activities as they pertain to government agencies and defense contracting. Now a transformation is underway to build up the commercial side of cyber. And that’s precisely what this panel will reinforce.
Cambridge headquartered AstraZeneca and its global biologics R & D arm MedImmune, plan to develop new therapies for respiratory disease through a five-year collaboration with Munich-based Ethris GmbH.
The Cambridge UK duo will pay Ethris €25 million upfront, plus research funding; Ethris is also eligible for future R & D milestones, including sales-related royalties on commercialisation.
Gaithersburg-based immunotherapy company Altimmune Inc. announced Tuesday it plans to expand into a new headquarters, but it’s not going far.
Altimmune (NASDAQ: ALT) officials said they plan to relocate existing employees — as well as new employees acquired as a result of its acquisition of Annapolis biodefense company PharmAthene Inc. — to a 14,000-square-foot space at 910 Clopper Road. The company is currently based at 19 Firstfield Road, less than a mile away.
Intralytix, Inc. announced that it received $17.5 million in new equity funding from Lesaffre, a French family group. This investment marks the beginning of a close collaboration between both companies to develop and commercialize bacteriophage-based products, for various benefits in human health and in other areas of mutual interest.
As a global key player in yeasts and fermentation, Lesaffre designs, manufactures and markets innovative solutions for Baking, Food taste & pleasure, Health care and Biotechnology. This new investment is perfectly in line with Lesaffre’s ongoing expansion strategy in nutrition and health. In 2015, Lesaffre had already announced the investment in Gnosis, an Italian company specialized in ingredients for the pharmaceutical, nutraceutical, cosmetic and veterinary industries.
Deadline Extended to August 24, 2017! Submit your proposal today
There’s still time to submit your proposal for the “Make Your Medical Device Pitch for Kids!” competition. Deadline extended to Thursday, August 24, 2017 at midnight PDT.
Up to six prizes totaling $250,000 will be awarded to the winning presentations at the nation’s leading pediatric innovation symposium on Sunday, September 24, 2017. Are you registered for the Symposium?
Join us for the 5th Annual Pediatric Device Innovation Symposium in San Jose, CA – one day before The MedTech Conference powered by AdvaMed.
It’s a results-driven day that brings together medical device innovators, investors, researchers, clinicians, and policy makers to stimulate pediatric device innovation and bring solutions to market faster for the benefit of children everywhere.
